Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Cntg crawled time : 11:00 save search
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
TAK | $13.15 -0.61% 0.0% 1.5M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 1.43%
H: 1.41%
C: -1.41%
partnership genetic takeda disorders
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
Published: 2023-10-10 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -0.68%
H: 1.66%
C: 1.66%
diagnostic offering
CENTOGENE to Participate in Upcoming Conferences in August
Published: 2023-08-07 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -2.91%
H: 2.0%
C: 0.0%
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
Published: 2023-07-14 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 1.35%
H: 4.0%
C: -2.0%
nasdaq
CENTOGENE to Participate in Upcoming Conferences in May
Published: 2023-05-05 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -3.0%
H: 3.01%
C: -0.81%
CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
Published: 2023-04-12 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 13.02%
H: 7.33%
C: -7.48%
centogenome rare solution neurodegenerative
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Published: 2023-04-11 (Crawled : 11:00) - globenewswire.com
TAK | $13.15 -0.61% 0.0% 1.5M
|
Health Technology
|
| O: -0.36%
H: 0.35%
C: -0.12%
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 12.46%
H: 0.0%
C: -11.04%
partnership genetic
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
Published: 2022-11-03 (Crawled : 11:00) - biospace.com/
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -0.01%
H: 2.14%
C: 2.14%
rare disease neurodegenerative
CENTOGENE to Participate in Upcoming Partnering Conferences in October 2022
Published: 2022-10-06 (Crawled : 11:00) - biospace.com/
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 0.0%
H: 2.68%
C: 2.68%
Outlook on the Hereditary Angioedema Global Market to 2030 - Size, Share, Outlook, and Opportunity Analysis
Published: 2022-09-05 (Crawled : 11:00) - prnewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
| Email alert
Add to watchlist
ADVM | $11.35 -2.24% -2.56% 68K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
| Email alert
Add to watchlist
IONS | $40.91 -1.52% -1.49% 1.2M
|
Health Technology
| Email alert
Add to watchlist
BCRX | News | $4.58 -0.65% -0.44% 4.1M
|
Health Technology
| Email alert
Add to watchlist
ARWR | $22.53 -4.82% -5.11% 860K
|
Health Technology
| Email alert
Add to watchlist
TAK | $13.15 -0.61% 0.0% 1.5M
|
Health Technology
| Email alert
Add to watchlist
global market hereditary angioedema
CENTOGENE to Present at Upcoming Investor & Partnering Conferences in September
Published: 2022-09-01 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -4.11%
H: 1.07%
C: -13.57%
Global $3.25+ Billion Lung Cancer Genomic Testing Markets to 2031: Focus on Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
DGX | $126.98 -0.35% 0.0% 890K
|
Health Services
|
| O: 0.43%
H: 2.47%
C: 1.85%
QGEN | $39.23 -0.23% 0.0% 800K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
LH M | $199.97 -0.97% 0.0% 680K
|
Health Services
|
| O: 2.35%
H: 2.94%
C: 2.21%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: 0.4%
H: 13.31%
C: 13.31%
A | $134.55 -1.65% -1.15% 1.8M
|
Health Technology
|
| O: 1.38%
H: 3.62%
C: 3.49%
ABT | News | $105.9 -3.03% 0.38% 11M
|
Health Technology
|
| O: 2.4%
H: 0.0%
C: 0.0%
VCYT | $18.86 -0.32% -0.26% 660K
|
Health Technology
|
| O: 0.75%
H: 15.68%
C: 15.57%
QGEN | $39.23 -0.23% 0.0% 800K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
OPK | $1.25 3.31% 3.59% 3.5M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 5.62%
ILMN | $118.29 0.51% 0.52% 1.6M
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: 0.0%
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -4.76%
H: 34.5%
C: 3.0%
genomic cancer
CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease
Published: 2022-06-13 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -4.21%
H: 4.39%
C: 3.52%
AGIO | $29.03 0.8% 0.79% 500K
|
Health Technology
|
| O: -6.12%
H: 2.7%
C: -2.36%
pyrukynd partnership blood rare disease children
CENTOGENE’s CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework
Published: 2022-05-25 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 0.55%
H: 0.56%
C: -0.92%
centocloud one
CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS) in Rare Disease Diagnostics
Published: 2022-05-23 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 2.29%
H: 0.0%
C: -1.56%
guidelines rare disease diagnostics diagnostic
CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022
Published: 2022-03-23 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -0.95%
H: 4.78%
C: -1.91%
results
CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer
Published: 2022-03-17 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -0.8%
H: 12.83%
C: 6.95%
expansion collaboration
CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases
Published: 2021-11-04 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 2.94%
H: 1.83%
C: -0.92%
AGIO | $29.03 0.8% 0.79% 500K
|
Health Technology
|
| O: 6.36%
H: 1.98%
C: -7.64%
disease partnership blood rare
CENTOGENE Reports Second Quarter 2021 Financial Results
Published: 2021-09-07 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: 6.75%
H: 0.0%
C: -6.68%
financial results results
CENTOGENE to Announce Second Quarter 2021 Financial Results on September 7, 2021
Published: 2021-09-01 (Crawled : 11:00) - globenewswire.com
CNTG | $0.48 -0.02% 0.14% 17K
|
Commercial Services
|
| O: -1.69%
H: 2.53%
C: -1.07%
financial results results
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
VNDA | News | $5.24 29.38% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.